Medtronic stock gets November 24 earnings date after ablation data
Published on 11/06/2026 at 17:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat matters for investors
- Medtronic will report fiscal second-quarter results on November 24, 2026.
- Positive registry findings support the company's cardiac ablation portfolio across atrial and ventricular arrhythmias.
- The next earnings release will test how the portfolio update translates into financial performance.
Medtronic added a clear investor milestone on Wednesday, November 4, 2026, when it announced that fiscal second-quarter results will be released on Tuesday, November 24. The company said the quarter ended on Friday, October 30, according to its results announcement.
A date for the next earnings test
Medtronic plans to publish summary financial information at 5:45 a.m. Central Time and begin its results webcast at 6:30 a.m. Central Time on November 24. The release will give investors a new view of the business after the company completed the separation of MiniMed in October.
The scheduled report is the next direct test of Medtronic's fiscal 2027 outlook. Investors will be watching whether the remaining cardiovascular, neuroscience and surgical portfolios sustain the momentum highlighted in the company's first-quarter update.
Clinical evidence supports cardiac focus
On October 22, Medtronic announced positive real-world registry results for the Sphere-9 catheter and PulseSelect pulsed field ablation system at the Asia Pacific Heart Rhythm Society meeting. The company's press release list describes results across atrial and ventricular arrhythmias.
The update strengthens the clinical case for Medtronic's cardiac ablation portfolio, but registry evidence alone does not establish a change in near-term revenue or earnings expectations. Commercial adoption, reimbursement and execution remain important checkpoints for the November report.
Share movement sets a separate checkpoint
The real-time quote of Medtronic stock was 91.79 euros on Lang & Schwarz at 17:32 CET on Friday, November 6, 2026. That was 1.56% below the 93.24-euro quote at 11:52 CET on Thursday, November 5, cited in the previous report.
Medtronic plc stock facts
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- NYSE ticker: MDT
- Lang & Schwarz quote: 91.79 euros on November 6, 2026, at 17:32 CET
- Movement since previous report: 1.56% below 93.24 euros on November 5, 2026
- Next results: November 24, 2026, for fiscal second quarter 2027
Broader healthcare and technology market conditions will shape how investors assess Medtronic ahead of the earnings release. See current market reports for the wider market setting.
